Sorafenib and LBH589 in Hepatocellular Carcinoma (HCC)
Clinical trial NCT00823290 · TERMINATED
Trial details
- NCT number
- NCT00823290
- Sponsor
- University of Erlangen-Nürnberg Medical School
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2010-12-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.